4//SEC Filing
Tsuchimoto Kim R 4
Accession 0001437749-25-022863
CIK 0001645469other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 9:06 PM ET
Size
10.8 KB
Accession
0001437749-25-022863
Insider Transaction Report
Form 4
Tsuchimoto Kim R
Director
Transactions
- Exercise of In-Money
Stock Options
2025-07-14−4,704→ 0 totalExercise: $0.01Exp: 2027-02-20→ Common Stock (4,704 underlying) - Exercise of In-Money
Common Stock
2025-07-14$0.01/sh+8,904$45→ 20,390 total - Sale
Common Stock
2025-07-14$40.00/sh−8,904$356,171→ 11,486 total - Exercise of In-Money
Stock Options
2025-07-14−4,200→ 0 totalExercise: $0.01Exp: 2026-04-04→ Common Stock (4,200 underlying)
Footnotes (4)
- [F1]This transaction involved a cash exercise of stock options.
- [F2]The shares were sold in multiple transactions at prices ranging from $40.00 to $40.25, inclusive. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Reflects options to purchase a total of 4,200 shares of common stock granted to Ms. Tsuchimoto on April 4, 2016, for her services as a director and prior officer of Monopar Therapeutics.The options vested 6/12ths upon the grant date and 3/12th every 6 months thereafter.
- [F4]Reflects options to purchase a total of 4,704 shares of common stock granted to Ms. Tsuchimoto on February 20, 2017, for her services as a director and prior officer of Monopar Therapeutics. The options vested 6/48ths upon the 6-month anniversary of the grant date and 1/48th per month thereafter.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001333516
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 9:06 PM ET
- Size
- 10.8 KB